TT HealthWatch

Program notes:

0:45 Imaging for cardiac stent placement

1:45 12 month target vessel failure

2:38 Treatment resistant depression and psychedelic medicine

3:38 Three dosages and psychological support

4:38 Adverse events same among all groups

5:38 Will it last longer than 60 days?

6:36 Need to compare head to head

7:00 One in thirteen people have achilles tendinopathy

8:00 Initial improvement with steroids then rapid decline

9:00 People must be patient

9:10 HER-2 positive early breast cancer giving chemo a miss

10:10 Utilizing PET imaging

11:10 A third responded just to antibodies

12:47 End

Program notes:

0:35 Continuous glucose monitoring in Type 2 diabetes not using insulin

1:40 Decreased HbA1c

2:35 Already shown to be beneficial in those using insulin

3:30 Cancer vaccines

4:30 Disease-free survival endpoint

5:32 If T-cell population increased

6:30 Pregnancy outcomes in women who donate kidneys

7:30 Matched 4-to-1 with nonkidney donors

8:30 Timing of kidney donation

9:15 AI collaboration for managing epilepsy

10:15 Links EEGs to AI and smartphone app

11:15 Patients requested continuation

12:45 End

Program notes:

0:40 Clinician use of AI clinically

1:40 703,000 active monthly users

2:40 How helpful is this?

3:40 More up to date

3:50 Prognostic model to estimate fetal compromise

4:50 Data from singleton births 

5:50 Fit4labour model

6:50 Could be used 8 hours before a problem

7:11 Drug coated balloons or stent

8:11 Indications are symptoms or high risk

8:40 US donor heart allocation

9:40 Best interests of their patient

10:40 Similar or significantly higher area under the curve 

11:40 Can identify a higher risk group

12:54 End

Program notes:

0:36 HPV vaccines and pregnancy outcomes

1:36 600,000+ births

2:36 What is the mechanism?

3:30 Adult ADHD

4:30 May see underperformance

5:30 Almost always methylphenidate or amphetamine

6:30 Public health significance

7:01 Hospital closures in the U.S.

8:01 Safety net, non-teaching hospitals closed more

9:03 Advance care planning in black and white older adults

10:04 Racially concordant or discordant facilitator

11:08 Self-guided planning

12:10 Not doing a good job offering ACP

13:59 End

Program notes:

0:40 Lean metabolic associated liver disease

1:40 Biopsy confirmed MASLD

2:40 Elastography for diagnosis

3:41 Liver transplant often needed

4:04 HT and thromboembolic disease

5:04 VTE, ischemic stroke and MI

6:04 Oral estrogen increased risk

7:07 LIquid cancer biopsy impact

8:07 Not had cancer compared to routine screening

9:07 Not seeing a positive impact

10:05 Inter-interval breast cancers

10:31 How to manage early septic shock

11:31 Main outcome alive and out of the hospital at day 90

12:30 Both are equally effective

13:20 End

Program notes:

0:33 Statins for older people without CVD

1:34 Followed for six years

2:34 Aged to 70 without CVD

3:00 Improving primary care for folks with chronic conditions

4:00 70,000 respondents

5:00 Long term relationship with a primary care provider

6:00 Continuity and coordination can be delivered at scale

7:09 Treating advanced breast cancer

8:10 Mutation in estrogen receptor

9:12 Targeting specific mutations

10:00 A new target for managing asthma and COPD

11:00 Healthy volunteers and patients with asthma

12:00 Typically treated with immunosuppression

13:05 End

Program notes:

0:40 Structured exercise after cancer

1:40 Moderate evidence

2:40 Improves overall survival

3:41 Improves drug penetration

4:00 Colonoscopy intervals after polyp removal

5:00 Five-year cumulative incidence same as three years

6:03 Covid vaccination and immune checkpoint therapy

7:03 Mortality as primary outcome

8:04 Multiple benefits of vaccination

9:03 Other vaccines of benefit?

9:50 Does sodium bicarbonate help in critical illness and shock

10:50 Metabolic acidosis tx

11:50 Largely futile

12:37 End

Program notes:

0:37 New stroke therapy

1:37 Use of IV for 10 days after stroke

2:37 Present late after a stroke

3:39 Long term outcomes of top-down therapy in Crohn's

4:40 Outcomes up to five years

5:40 Early TNF use from diagnosis improves outcomes

6:42 No real downside

7:38 How much oxygen for 32–35-week neonates?

8:34 Ongoing respiratory support needed?

9:34 Not hypoxic to begin with

9:50 Feeding eggs and peanuts during pregnancy

10:50 Did not impact risk for infant allergy

11:50 One third dropped out

13:03 End

Program notes:

0:33 Vaccines for RSV, flu, and Covid

1:35 Studies available right now

2:33 Reduction of hospital encounters for infants

3:33 Maternal vaccination for RSV

4:34 Gene silencing therapy for cardiomyopathy

5:35 Decreased primary outcome about 20%

6:35 Should we be screening?

7:06 A new protein to pinpoint preeclampsia

8:05 Low levels in first trimester

9:08 Anchors embryo to uterus

10:05 A new therapy for COPD exacerbations

11:05 Phase three trial of monoclonal

12:34 End

Program notes:

0:44 EKG monitoring and syncope

1:45 No difference when monitored

2:45 Why not try monitoring?

3:13 Catheter directed thrombolysis in PE

4:14 Composite of death from any cause

5:14 Assessment for intermediate or high risk

6:16 Treatment not onerous

6:45 Afib ablation versus sham

7:45 Did not improve quality of life

8:45 Preprocedure assessment of psychological state?

9:13 Digital intervention to protect cognitive health

10:13 Verbal reasoning at 12 months

11:13 As long as internet is available

12:15 What happens at five-year follow-up

13:09 End